Correlation Between IBio, Common and Quoin Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both IBio, Common and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IBio, Common and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iBio, Common Stock and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on IBio, Common and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IBio, Common with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IBio, Common and Quoin Pharmaceuticals.

Diversification Opportunities for IBio, Common and Quoin Pharmaceuticals

-0.67

Correlation Coefficient

IBio, Common  Quoin Pharmaceuticals

Excellent diversification

The 3 months correlation between IBio, and Quoin is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding iBio, Common Stock and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and IBio, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iBio, Common Stock are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of IBio, Common i.e., IBio, Common and Quoin Pharmaceuticals go up and down completely randomly.

Pair Corralation between IBio, Common and Quoin Pharmaceuticals

Given the investment horizon of 90 days iBio, Common Stock is expected to generate 0.91 times more return on investment than Quoin Pharmaceuticals. However, iBio, Common Stock is 1.1 times less risky than Quoin Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.1 per unit of risk. If you would invest  248.00  in iBio, Common Stock on December 20, 2024 and sell it today you would earn a total of  238.00  from holding iBio, Common Stock or generate 95.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

iBio, Common Stock  vs.  Quoin Pharmaceuticals Ltd

iBio, Common Stock

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in iBio, Common Stock are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, IBio, Common displayed solid returns over the last few months and may actually be approaching a breakup point.

Quoin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Quoin Pharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with IBio, Common and Quoin Pharmaceuticals

The main advantage of trading using opposite IBio, Common and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IBio, Common position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.

The idea behind iBio, Common Stock and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.